Publications
Publications
Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
Partnership expanded to include vascular trauma repair outside of the United States. Fresenius Medical Care is a leading participant in fully committed PIPE financing transaction. Durham, N.C. – June 11, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing
June 11, 2021
No Comments
Humacyte to Provide Investor Update on June 7
Durham, N.C. – June 4, 2021 – Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced an investor update presentation will be available at 9:00 a.m. ET on Monday, June 7
June 4, 2021
No Comments
“Patency of ePTFE Arteriovenous Graft Placements in Hemodialysis Patients: Systematic Literature Review and Meta-analysis”
Article excerpt would be here.
June 3, 2021
No Comments
March 11, 1021
"Patency of ePTFE Arteriovenous Graft Placements in Hemodialysis Patients: Systematic Literature Review and Meta-analysis"
"Arterial Reconstruction with Human Bioengineered Acellular Blood Vessels in Patients with Peripheral Arterial Disease"
"Bioengineered Human Blood Vessels"
"Challenges and Novel Therapies for Vascular Access in Haemodialysis"
"Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage 2012-2014"
"Bioengineered Human Acellular Vessels Recellularize and Evolve into Living Blood Vessels after Human Implantation"
"Clinical Implementation of the Humacyte Human Acellular Vessel: Implications for Military and Civilian Trauma Care"
"Cost Attributable to Arteriovenous Fistulae And Arteriovenous Graft Placements in Hemodialysis Patients with Medicare Coverage"
"Susceptibility of EPTFE Vascular Grafts and Bioengineered Human Acellular Vessels to Infection"
"Arteriovenous Fistulae for Hemodialysis: A Systematic Review and Meta-Anaylsis of Efficacy and Safety Outcomes"
"Bioengineered Hemodialysis Access Graft"
"Bioengineered Human Acellular Vessels for Dialysis Access in Patients with End-Stage Renal Disease: Two Phase 2 Single-Arm Trials"
"An Early Study on the Mechanisms that Allow Tissue-Engineered Vascular Grafts to Resist Intimal Hyperplasia"
"Readily Available Tissue-Engineered Vascular Grafts"
